TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
Cell
; 184(10): 2618-2632.e17, 2021 05 13.
Article
in En
| MEDLINE
| ID: mdl-33836156
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
DNA Topoisomerases, Type I
/
Topotecan
/
Topoisomerase I Inhibitors
/
SARS-CoV-2
/
COVID-19 Drug Treatment
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Cell
Year:
2021
Type:
Article
Affiliation country:
United States